Perhaps I'll speak. Dr. Sharma is not a witness on the panel this afternoon.
Health Canada has a very rigorous, independent regulatory organization. It has very high standards for safety, quality and efficacy. We published our standards for this in the fall, and they're aligned with those of other leading regulators.
The review process involves teams of scientists from a variety of disciplines. We put in place an interim order to accelerate the reviews, without sacrificing any of the intense scientific analysis required to evaluate the vaccine submissions relative to those standards. This was enabled through a process of rolling review—that is, being able to look at the submission as it was provided—and by having multiple teams of reviewers associated with each submission. That way, they could work around the clock with the information provided, and, in collaboration with other leading regulators, ensure that every aspect of the review was looked at and decisions were taken in a timely fashion.